Illustris Pharmaceuticals

Illustris Pharmaceuticals Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $5M
Latest Deal Amount

Illustris Pharmaceuticals General Information

Description

Developer of molecule delivery technology designed to deliver ingredients which can permeate tissue structures. The company's Illustris Technology Platform provides a pathway through tissue structures that delivers active ingredients which deploys decoy, distract and relax anchors and binds tissue cells, enabling patients to optimize the absorption of compounds typically delivered through skin, eyes and mucous surfaces.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Drug Delivery
Primary Office
  • 4030 Fabian Way
  • Suite B
  • Palo Alto, CA 94303
  • United States
+1 (650) 000-0000

Illustris Pharmaceuticals Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Illustris Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A2) 27-Feb-2017 $5M 00.00 000.00 Completed Startup
1. Early Stage VC (Series A1) 07-Nov-2016 00.00 00.00 0000 Completed Product Development

Illustris Pharmaceuticals Cap Table

To view Illustris Pharmaceuticals‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 0,000,000 00.000000 00.00 00.00 00 00.00 000
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000

Illustris Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Mark Prygocki Chief Executive Officer & Board Member
Siak Tan Co-Founder & Board Member
Jacob Waugh MD Co-Founder, Chief Scientific Officer & Board Member
Janifer Yeo-Tan Co-Founder

Illustris Pharmaceuticals Board Members (5)

Name Representing Role Since
Andrew Hirschberg Illustris Pharmaceuticals Board Member 000 0000
Jacob Waugh MD Illustris Pharmaceuticals Co-Founder, Chief Scientific Officer & Board Member 000 0000
Jonah Shacknai JD Illustris Pharmaceuticals Chairman 000 0000
Mark Prygocki Illustris Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Siak Tan Illustris Pharmaceuticals Co-Founder & Board Member 000 0000

Ready to get started?

Request a free trial